We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This study assesses the impact on crime of the Metropolitan Police’s Operation BLUNT 2, which ran from May 2008 to April 2011.
The CMA investigated the anticipated acquisition by Cochlear Limited of the hearing implants business of Demant A/S, known as Oticon Medical.
Find out about changes to the Business Investment Relief rules from 6 April 2017.
Employment Appeal Tribunal Judgment of Judge Shanks on 22 February 2024.
Responding to suspected breaches of planning control.
Join us as a Research Officer to launch a brilliant career in Government Social Research.
MHRA performance metrics for clinical trials and established medicines assessment.
This report series contains publications of substantial scientific work carried out by the Health Protection Agency's Radiation Protection Division.
The CMA is investigating the anticipated joint venture between Vodafone Group Plc and CK Hutchison Holdings Limited concerning Vodafone Limited and Hutchison 3G UK Limited.
This is an explanation of how we process personal data.
Northern Region Judge A. M. Davies and Members J. Jacobs Sitting on 11 October 2019
Advice for institutions on the financial support young people may be able to access to help them participate in education and training.
The CMA investigated the anticipated acquisition by Theramex HQ UK Limited of the European Rights to Viatris’ Femoston and Duphaston Products.
Find out how to report information to HMRC using the Automatic Exchange of Information (AEOI) if you are a financial institution.
This guidance summarises our approach to pharmacovigilance
Protection in the EU for databases produced in the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).